|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,860.00 KRW | +0.80% |
|
+11.73% | -21.31% |
Company Valuation: Englewood Lab, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 99,141 | 1,70,864 | 1,01,127 | 2,64,839 | 1,35,499 | 2,23,712 |
| Change | - | 72.34% | -40.81% | 161.89% | -48.84% | 65.1% |
| Enterprise Value (EV) 1 | 1,11,906 | 1,89,873 | 1,15,151 | 2,59,973 | 1,27,057 | 2,00,892 |
| Change | - | 69.67% | -39.35% | 125.77% | -51.13% | 58.11% |
| P/E | 32.2x | 11.4x | 13.9x | 12.8x | 6.9x | 9.02x |
| PBR | 1.63x | 2.11x | 1.09x | 2.3x | 0.94x | 1.36x |
| PEG | - | 0x | -0.3x | 0x | -1.28x | 0.3x |
| Capitalization / Revenue | 0.72x | 1.06x | 0.67x | 1.28x | 0.74x | 1.03x |
| EV / Revenue | 0.82x | 1.18x | 0.76x | 1.26x | 0.7x | 0.93x |
| EV / EBITDA | 9.09x | 8.95x | 8.09x | 7.82x | 5.31x | 4.72x |
| EV / EBIT | 14.2x | 11.2x | 11.7x | 9.01x | 6.76x | 5.38x |
| EV / FCF | 24.2x | -11.3x | 493x | 16.7x | -26.8x | 20x |
| FCF Yield | 4.13% | -8.85% | 0.2% | 6% | -3.73% | 5% |
| Dividend per Share 2 | - | - | - | - | 100 | 201 |
| Rate of return | - | - | - | - | 1.47% | 1.79% |
| EPS 2 | 155.1 | 754.9 | 365.7 | 1,044 | 987.9 | 1,249 |
| Distribution rate | - | - | - | - | 10.1% | 16.1% |
| Net sales 1 | 1,37,168 | 1,60,816 | 1,51,509 | 2,06,784 | 1,82,220 | 2,16,790 |
| EBITDA 1 | 12,307 | 21,209 | 14,230 | 33,249 | 23,912 | 42,601 |
| EBIT 1 | 7,869 | 16,905 | 9,882 | 28,855 | 18,795 | 37,368 |
| Net income 1 | 3,082 | 14,997 | 7,265 | 20,742 | 19,628 | 24,815 |
| Net Debt 1 | 12,766 | 19,010 | 14,023 | -4,865 | -8,442 | -22,820 |
| Reference price 2 | 4,990.00 | 8,600.00 | 5,090.00 | 13,330.00 | 6,820.00 | 11,260.00 |
| Nbr of stocks (in thousands) | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 |
| Announcement Date | 17/03/21 | 16/03/22 | 15/03/23 | 21/03/24 | 20/03/25 | 16/03/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 12Cr | ||
| 29.03x | 4.53x | 18.74x | 2.02% | 23TCr | ||
| 59.68x | 8.5x | 33.11x | 0.25% | 5.24TCr | ||
| 26.59x | 5.05x | 19.02x | 1.19% | 935.58Cr | ||
| 26.93x | 1.31x | 10.11x | 2.17% | 686Cr | ||
| 21.2x | 1.49x | 9.51x | 1.31% | 490.16Cr | ||
| 40.38x | 2.68x | 13.24x | -.--% | 454.24Cr | ||
| 24.61x | 2.42x | 12.63x | 2.68% | 382.36Cr | ||
| 14.86x | 1.66x | 9.23x | 2.92% | 346.18Cr | ||
| 20x | 2.48x | 12.19x | 3.83% | 258.31Cr | ||
| Average | 29.25x | 3.35x | 15.31x | 1.82% | 3.22TCr | |
| Weighted average by Cap. | 33.68x | 4.98x | 20.46x | 1.71% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A950140 Stock
- Valuation Englewood Lab, Inc.
Select your edition
All financial news and data tailored to specific country editions
















